Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
    • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Treatments
    • Research
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Clinical practice
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    Exercise the Evidence: How I Moved From an Idea to Program Development
    Patient quality of life
    Exercise the Evidence: How I Moved From an Idea to Program Development
    November 19, 2021
    The Case of the Missing Oral Mucositis
    Radiation therapy
    The Case of the Missing Oral Mucositis
    October 22, 2021
    What It’s Like to Compete in the ONS Hackathon™
    Oncology nurse pride
    What It’s Like to Compete in the ONS Hackathon™
    September 17, 2021
    The Case of the Swift Sepsis Response
    Oncologic emergencies
    The Case of the Swift Sepsis Response
    September 03, 2021
    The Case of the GVHD Double-Take
    Treatment side effects
    The Case of the GVHD Double-Take
    August 24, 2021
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
    • Home

    Author Content

    Chemotherapy

    Outpatient Oncology Drug Series: Doxorubicin Is the Infamous Red Devil

    Doxorubicin is a cytotoxic chemotherapy drug and an antitumor antibiotic in the anthracycline group. You’ll see this drug quite a lot In the outpatient setting, and most commonly, you’ll use it to treat patients with breast cancer.
    April 10, 2015
    Cancer treatments

    Outpatient Oncology Drug Series: Don't Forget Leucovorin Calcium, the Superhero Sidekick

    I think it's helpful to be able to educate your patients on the reasons for receiving each individual drug in a combination regimen. Although leucovorin is not a chemotherapy agent or generally used as a stand-alone drug, it certainly is important. Leucovorin has a specific function, and you should be able to explain its purpose.
    March 16, 2015
    Cancer treatments

    Outpatient Oncology Drug Series: Confidently Administer 5-Fluorouracil

    5-Fluorouracil, or more commonly referred to as simply 5-FU, is a cytotoxic chemotherapy drug that is classified as an antimetabolite and, within that class, belongs to the pyrimidine analogue family.
    February 23, 2015
    Adjuvant therapy

    Outpatient Oncology Drug Series: Oxaliplatin Hates the Cold

    Oxaliplatin is a cytotoxic (toxic to normal cells) chemotherapy drug that is classified as an alkylating agent as well as a platinum analogue. It is indicated for a number of different cancers including colorectal, esophageal, gastric, hepatobiliary, Non-Hodgkin lymphoma, ovarian, pancreatic, and testicular cancer.
    January 16, 2015
    Chemotherapy

    Outpatient Oncology Drug Series: Paclitaxel Packs a Punch

    Oncology nursing is a field in which you are challenged on a regular basis to expand your knowledge because of the constantly changing field of treatments being used. Whether you are new or seasoned, it can be difficult to stay on top of the numerous agents used for varying diagnoses.
    December 12, 2014

    To discuss the information in this article with other oncology nurses, visit the ONS Communities.

    To report a content error, inaccuracy, or typo, email pubONSVoice@ons.org.

    Jill Weberding BSN, MPH, RN, OCN®
     
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap

  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
    • © Copyright 2021 Oncology Nursing Society
     
    Back to Top ▲